Navigation Links
AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
Date:9/17/2007

Aetna, McCluskey was Vice President of Medical Affairs for Medpartners Medical Management in Tampa. She previously served as Internist/Medical Director of Bridgeton Health Center in St. Louis. McCluskey began her career as an Urgent Care Physician in St. Louis. A graduate of St. Louis University and the St. Louis University School of Medicine, she completed her residency in Internal Medicine at Jewish Hospital/Washington University in St. Louis.

AMERIGROUP offers disease management programs for 11 different conditions, ranging from asthma and diabetes to AIDS and schizophrenia, eight of which are accredited by the National Committee for Quality Assurance. The Company's health plan in the District of Columbia has also obtained accreditation and a rating of commendable from the NCQA. All AMERIGROUP health plans in the District and nine states offer members a range of initiatives that are designed to connect the 1.5 million members with quality, preventive healthcare programs that target the specific needs of low-income Americans.

About AMERIGROUP Corporation

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.5 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com .

CONTACTS:

Investors: Julie Loftus Trudell News Media: Kent Jenkins, Jr.

AMERIGROUP Corporation AMERIGROUP Corporation

Senior Vice President, Senior Vice President,

Investor Relations Communications

(
'/>"/>

SOURCE AMERIGROUP Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
11. EU medical chief says Europe ready for bird flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...ging that can detect gastrointestinal cancers with...ethods can be soon availed by residents in Delhi. ...visualization of the internal organs through a tel...s). Direct visualization of the internal regions o...
...amination of fluid filled plastic teething ring, m...., parents have been urged by the Food and Drug Ad...h the product. The contaminated liquid if swallow...ral cavity, could lead to sickness. Malnourished i...
...rsity Medical Center have found that the lethal im...than anticipated. Researchers from the Mailman Sch...ter also collaborated in this study, which// appea...e. "Our research illustrates that programs to prev...
... new reasons and factors responsible for unhealthy...me from soft drink incentives, and parents who bri...This new information may be useful to school welln...oping wellness policies as mandated by the Child N...
Other Medicine News:Health News:Gum Disease Affects Diabetic Children Earlier Than Anticipated 2Health News:The trident of unhealthy teen choices is early Lunch, Soft Drink Machine Income and Parents who relent 2
(Date:7/23/2008)...uly 23 /- Sound Pharmaceuticals (SPI)... with the FDA for the clinical,testing of a propri...,chemotherapy induced hearing loss or ototoxicity....ll be tested in advanced stage lung cancer,and hea...d chemotherapy.,This marks the second development ...
(Date:7/23/2008)...SCO, July 23 /- InCode BioPharmaceuti...oday announced preclinical test,results demonstrat... for,the treatment of the rare chronic blood disor... complete results will be presented at the XXII,In...and, September 28,2008., The only treatment curr...
(Date:7/22/2008)...fficacy results from a multi-center 293-patient Eu...onto Stock Exchange Symbol: CYT, MONTREAL, July 2...s,Inc., the global leader in cryotherapy products ... results previously presented from three,European ...ctic Front(R),were published earlier today in the...
(Date:7/22/2008)...strates Feasibility and Efficacy of Treating Patie...ncer, SAN FRANCISCO, and YONGIN-SI, South Korea, ...sco, CA and Ottawa, Ontario), and its South,Korean...ovel findings from,a Phase I clinical trial of its...hat the product was well-tolerated and resulted in...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 1APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 2Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 1Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 2New study finds resistant organisms at core of soft contact lens corneal infections 10235 1New study finds resistant organisms at core of soft contact lens corneal infections 10235 2Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast 2766 1
...ne, the U.S.-based subsidiary of,Pharmexa A/S, pre...gram today at the Influenza Conference entitled, "...Toronto, Ontario, Canada. The,data show that a "un...immune responses can protect transgenic mice again..., HORSOLM, Denmark, June 21, 2007-Pharmexa-Epimmun...
... June 21, 2007 - “In anaplastic,astrocytoma,...erior,to temozolomide,” Prof. Albert Wong, M...nted on the international Phase,IIb study with the...by Antisense Pharma. Prof. Wong discussed the resu...on central nervous system tumors,at the 43rd Annua...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...es, the Advantage Smart Table goes up to 6 inches ...h to accommodate all open procedures. Controlled w...sitions for various surgeons and procedures. One b...to level. The simple unidirectional set-up of the ...
Inquire
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein.
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability.
Medicine Products: